CryoLife

CryoLife, headquartered in Georgia, is a leader in the processing and distribution of human tissues for use in cardiac and vascular surgeries. CryoLife using its proprietary SynerGraft® technology processes the CryoValve® SG pulmonary heart valve and CryoPatch® SG pulmonary cardiac patch. CryoLife’s BioGlue® Surgical Adhesive is approved in the U.S. for use as an adjunct to sutures and staples to help control bleeding, CE marked in the European Community, approved in Canada and Australia for use in soft tissue repair, and in Japan for use in the repair of aortic dissections. CryoLife’s CardioGenesis specializes in the treatment of severe angina using a laser console system and fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization (TMR). CryoLife markets the HeRO® Graft, which provides vascular access for hemodialysis patients. CryoLife distributes PerClot®, an absorbable powdered hemostat, in international markets. CryoLife’s BioFoam® Surgical Matrix is CE marked in the European Community for use as an adjunct to hemostasis.
Company Growth (employees)
Type
Public
HQ
Kennesaw, US
Founded
1984
Size (employees)
665 (est)+24%
CryoLife was founded in 1984 and is headquartered in Kennesaw, US

Key People at CryoLife

Steven G. Anderson

Steven G. Anderson

Chairman, President and CEO
Thomas F. Ackerman

Thomas F. Ackerman

Thomas F. Ackerman Executive Vice President and CFO

CryoLife Office Locations

CryoLife has offices in Kennesaw, Guildford, Singapore
Kennesaw, US
Singapore, SG
Guildford, GB

CryoLife Metrics

CryoLife Summary

Market capitalization

$557.4 m

Closing share price

$17
CryoLife's current market capitalization is $557.4 m.

CryoLife Financials

CryoLife's revenue is $180.4 m in FY, 2016 which is a 23.6% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$140.8 m$144.6 m$145.9 m$180.4 m

Revenue growth, %

2.8%0.9%23.6%

Gross profit

$90.4 m$91.3 m$90.7 m

Operating expense total

$76.6 m$82.5 m$85.4 m

EBIT

$13.8 m$8.8 m$5.4 m

Net Income

$16.2 m$7.3 m$4 m$10.8 m

Operating cash flow

$24.6 m($4.3 m)$4.2 m

CryoLife Market Value History

CryoLife Online Presence

CryoLife Company Life

You may also be interested in